Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | XDH | P47989 | 2/20 | 0.43 |
| ▸ | CDK4 | P11802 | 3/20 | 0.42 |
| ▸ | CCND1 | P24385 | 3/20 | 0.42 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.42 |
| ▸ | CDK1 | P06493 | 2/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.42 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.35 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1310214 | 0.81 | ALDH1A1 (0.75) | ALDH1A1TRPA1LMNAALOX5MAPK1 | |
| SCHEMBL1310216 | 0.81 | ALDH1A1 (0.75) | ALDH1A1TRPA1LMNAALOX5MAPK1 | |
| SCHEMBL210914 | 0.78 | MAOB (0.33) | ALDH1A1TRPA1LMNAALOX5KDM4E | |
| SCHEMBL152100 | 0.78 | MAOB (0.33) | ALDH1A1TRPA1LMNAALOX5KDM4E | |
| Cinnamaldehyde SCHEMBL28538253 | 0.77 | ALDH1A1 (0.95) | ALDH1A1TRPA1LMNAALOX5MAPK1 | |
| SCHEMBL4629980 | 0.75 | MAOB (0.36) | ALDH1A1TRPA1LMNAALOX5MAPK1 | |
| Cinnamaldehyde SCHEMBL25267814 | 0.74 | ALDH1A1 (1.00) | ALDH1A1TRPA1LMNAALOX5MAPK1 | |
| Cinnamaldehyde SCHEMBL3442 | 0.74 | ALDH1A1 (1.00) | ALDH1A1TRPA1LMNAALOX5MAPK1 | |
| Cinnamaldehyde SCHEMBL2203965 | 0.74 | ALDH1A1 (1.00) | ALDH1A1TRPA1LMNAALOX5MAPK1 | |
| Cinnamic Aldehyde SCHEMBL1866630 | 0.74 | ALDH1A1 (1.00) | ALDH1A1TRPA1LMNAALOX5MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2616424-B1 | METHOD FOR PRODUCING 2-METHYL-3-(4-TERT-BUTYLPHENYL)-PROPANAL HAVING HIGH PARA-ISOMER PURITY | BASF SE (DE) | 2015-08-26 | — | — | EP | claimed |
| US-8614358-B2 | Process for preparing 2-methyl-3-(4-tert-butylphenyl)propanal with high para-isomer purity | BASF SE (DE) | 2013-12-24 | — | — | US | claimed |
| US-20120071696-A1 | PROCESS FOR PREPARING 2-METHYL-3-(4-TERT-BUTYLPHENYL)PROPANAL WITH HIGH PARA-ISOMER PURITY | BASF SE (DE) | 2012-03-22 | — | — | US | claimed |
| US-8614358-B2 | Process for preparing 2-methyl-3-(4-tert-butylphenyl)propanal with high para-isomer purity | BASF SE (DE) | 2013-12-24 | — | — | US | disclosed |
| US-20120071696-A1 | PROCESS FOR PREPARING 2-METHYL-3-(4-TERT-BUTYLPHENYL)PROPANAL WITH HIGH PARA-ISOMER PURITY | BASF SE (DE) | 2012-03-22 | — | — | US | disclosed |
| US-6683092-B1 | BREAST AND/OR PROSTATE CANCER | ALLERGAN, INC. | 2004-01-27 | — | — | US | disclosed |
| EP-0541640-B1 | PROCESS FOR LIGHT-INDUCED ORIENTATION OF LIQUID CRYSTAL POLYMERS FOR THE PURPOSE OF REVERSIBLE DATA STORAGE | AGFA GEVAERT AG (DE) | 1996-03-20 | — | — | EP | disclosed |
| EP-0541640-A1 | LIQUID CRYSTAL POLYMERS AND PROCESS FOR LIGHT-INDUCED ORIENTATION OF SAID POLYMERS FOR THE PURPOSE OF REVERSIBLE DATA STORAGE. | AGFA GEVAERT AG (DE) | 1993-05-19 | — | — | EP | disclosed |
| EP-0541640-A1 | LIQUID CRYSTAL POLYMERS AND PROCESS FOR LIGHT-INDUCED ORIENTATION OF SAID POLYMERS FOR THE PURPOSE OF REVERSIBLE DATA STORAGE. | AGFA GEVAERT AG (DE) | 1993-05-19 | — | — | EP | disclosed |
| WO-1992002930-A1 | LIQUID CRYSTAL POLYMERS AND PROCESS FOR LIGHT-INDUCED ORIENTATION OF SAID POLYMERS FOR THE PURPOSE OF REVERSIBLE DATA STORAGE | AGFA-GEVAERT AG (DE) | 1992-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071696-A1 | PROCESS FOR PREPARING 2-METHYL-3-(4-TERT-BUTYLPHENYL)PROPANAL WITH HIGH PARA-ISOMER PURITY | HPD, PAH, PTMA | ALDH1A1 97/4885TRPA1 1415/4885LMNA 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.